Gene · 1033
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer. | J Exp Clin Cancer Res | 2024 | 38863037 | PubTator, text mining | PubMed |
| Reconstitution of nuclear envelope subdomain formation on mitotic chromosomes in semi-intact cells. | Cell Struct Funct | 2024 | 38839376 | PubTator, text mining | PubMed |
| The role of cyclin-dependent kinase inhibitor 3 in the proliferation and migration of renal cell carcinoma. | Chem Biol Interact | 2024 | 38825053 | PubTator, text mining | PubMed |
| N6-Methyladenosine modified circ-NAB1 modulates cell cycle and epithelial-mesenchymal transition via CDKN3 in endometrial cancer. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38814199 | PubTator, text mining | PubMed |
| Transcriptome Analysis of BAFF/BAFF-R System in Murine Nephrotoxic Serum Nephritis. | Int J Mol Sci | 2024 | 38791453 | PubTator, text mining | PubMed |
| Enhancing chronic wound healing with Thai indigenous rice variety, Kaab Dum: Exploring ER stress and senescence inhibition in HaCaT keratinocyte cell line. | PLoS One | 2024 | 38748716 | PubTator, text mining | PubMed |
| FTO blocks RNA translational activity via the loss of N6-methyladenosine methylation at 5' UTR regulated by RBM5 in cisplatin-resistant NSCLC. | J Cell Physiol | 2024 | 38742685 | PubTator, text mining | PubMed |
| SSH3 promotes pancreatic cancer proliferation and migration by activating the notch signaling pathway. | Am J Cancer Res | 2024 | 38726290 | PubTator, text mining | PubMed |
| Human pan-cancer analysis of the predictive biomarker for the CDKN3. | Eur J Med Res | 2024 | 38720365 | PubTator, text mining | PubMed |
| [Auxiliary diagnosis and prognosis evaluation of KIF4A, RAD51AP1 and CDKN3 in esophageal cancer]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2024 | 38715507 | PubTator, text mining | PubMed |
| Olmutinib Reverses Thioacetamide-Induced Cell Cycle Gene Alterations in Mice Liver and Kidney Tissues, While Wheat Germ Treatment Exhibits Limited Efficacy at Gene Level. | Medicina (Kaunas) | 2024 | 38674285 | PubTator, text mining | PubMed |
| Quiescent Adult Neural Stem Cells: Developmental Origin and Regulatory Mechanisms. | Neurosci Bull | 2024 | 38656419 | PubTator, text mining | PubMed |
| Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells. | Cancer Discov | 2024 | 38587317 | PubTator, text mining | PubMed |
| Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells. | Biomol Concepts | 2024 | 38525814 | PubTator, text mining | PubMed |
| Distribution and bulk flow analyses of the intraflagellar transport (IFT) motor kinesin-2 support an "on-demand" model for Chlamydomonas ciliary length control. | Cytoskeleton (Hoboken) | 2024 | 38456596 | PubTator, text mining | PubMed |
| [Oral History in Medicine and Narrative Medicine - a Commentary on the Question of Vulnerability]. | NTM | 2024 | 38411660 | PubTator, text mining | PubMed |
| Construction of an Anoikis-Related Gene Prognostic Signature and Identification of ANGPTL4 as a Key Oncogene in Lung Adenocarcinoma. | Mol Biotechnol | 2024 | 38381376 | PubTator, text mining | PubMed |
| The role of Cyclin Dependent Kinase Inhibitor 3 (CDKN3) in promoting human tumors: Literature review and pan-cancer analysis. | Heliyon | 2024 | 38380029 | PubTator, text mining | PubMed |
| Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. | J Cancer | 2024 | 38356706 | PubTator, text mining | PubMed |
| Identification of crucial anoikis-related genes as novel biomarkers and potential therapeutic targets for lung adenocarcinoma via bioinformatic analysis and experimental verification. | Aging (Albany NY) | 2024 | 38345559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1033/papers?page=9